Cargando…

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences

The catastrophic outbreak of coronavirus disease 2019 (COVID-19) is currently a public emergency. Adult-onset Still’s disease (AOSD) is an autoinflammatory disease characterized by life-threatening complications. Systemic hyperinflammation and cytokine storm play a critical role in the pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Jianfen, Ma, Yuning, Jia, Jinchao, Wang, Mengyan, Teng, Jialin, Shi, Hui, Liu, Honglei, Su, Yutong, Ye, Junna, Sun, Yue, Cheng, Xiaobing, Chi, Huihui, Liu, Tingting, Zhu, Dehao, Zhou, Zhuochao, Wan, Liyan, Wang, Zhihong, Wang, Fan, Qiao, Xin, Chen, Xia, Zhang, Hao, Tang, Zihan, Yang, Chengde, Hu, Qiongyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856388/ https://www.ncbi.nlm.nih.gov/pubmed/33552062 http://dx.doi.org/10.3389/fimmu.2020.603389

Ejemplares similares

Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still’s disease pathogenesis
por: Jia, Jinchao, et al.
Publicado: (2022)

Current and emerging biological therapy in adult-onset Still’s disease
por: Ma, Yuning, et al.
Publicado: (2021)

Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still’s Disease: A Machine Learning Study
por: Jia, Jinchao, et al.
Publicado: (2020)

Association of the Leukocyte Immunoglobulin‐like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult‐Onset Still’s Disease
por: Wang, Mengyan, et al.
Publicado: (2021)

Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
por: Hu, Qiongyi, et al.
Publicado: (2020)

Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still’s Disease
por: Sun, Yue, et al.
Publicado: (2020)

Serum sTREM-1 in adult-onset Still’s disease: a novel biomarker of disease activity and a potential predictor of the chronic course
por: Wang, Zhihong, et al.
Publicado: (2020)

Neutrophil-derived lipocalin-2 in adult-onset Still’s disease: a novel biomarker of disease activity and liver damage
por: Jia, Jinchao, et al.
Publicado: (2020)

A Cohort Study of Liver Involvement in Patients With Adult-Onset Still's Disease: Prevalence, Characteristics and Impact on Prognosis
por: Chi, Huihui, et al.
Publicado: (2020)

Pregnancy Outcomes in Patients With Adult-Onset Still's Disease: A Cohort Study From China
por: Wang, Zhihong, et al.
Publicado: (2020)

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease
por: Su, Yutong, et al.
Publicado: (2019)

Methylenetetrahydrofolate Reductase 677T Allele Is a Risk Factor for Arterial Thrombosis in Chinese Han Patients with Antiphospholipid Syndrome
por: Tang, Zihan, et al.
Publicado: (2022)

Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
por: Teng, Jialin, et al.
Publicado: (2020)

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still’s disease
por: Hu, Qiongyi, et al.
Publicado: (2019)

COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study
por: Pan, Haoyu, et al.
Publicado: (2022)

Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses
por: Jia, Jinchao, et al.
Publicado: (2019)

Total metabolic lesion volume of lymph nodes measured by (18)F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease
por: Wan, Liyan, et al.
Publicado: (2021)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Differential diagnostic performance of PET/CT in adult-onset still’s disease and lymphoma: a retrospective pilot study
por: Wan, Liyan, et al.
Publicado: (2022)

The clinical pattern differentiates ANCA-positive infective endocarditis patients from ANCA-associated vasculitis patients: a 23 years’ retrospective cohort study in China and follow-ups
por: Wang, Fan, et al.
Publicado: (2022)

Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai
por: Zhou, Zhuochao, et al.
Publicado: (2020)

Value of the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the inflammatory myopathy population
por: Shi, Yunjing, et al.
Publicado: (2023)

Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients
por: Han, Jing, et al.
Publicado: (2022)

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker
por: Hu, Qiongyi, et al.
Publicado: (2018)

CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis
por: Tang, Zihan, et al.
Publicado: (2023)

Continuation, reduction, or withdrawal of tofacitinib in patients with rheumatoid arthritis achieving sustained disease control: a multicenter, open-label, randomized controlled trial
por: Wang, Mengyan, et al.
Publicado: (2023)

“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
por: Liu, Tingting, et al.
Publicado: (2020)

Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients
por: Shi, Hui, et al.
Publicado: (2017)

Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis
por: Hu, Qiongyi, et al.
Publicado: (2019)

Protective Role of Rheumatic Diseases Against Hepatitis B Virus Infection and Human Leukocyte Antigen B27 Highlighted
por: Ye, Junna, et al.
Publicado: (2022)

Both HLA class I and II regions identified as genome-wide significant susceptibility loci for adult-onset Still's disease in Chinese individuals
por: Li, Zhiqiang, et al.
Publicado: (2020)

Evaluating hypercoagulability in new‐onset systemic lupus erythematosus patients using thromboelastography
por: Gong, Huiyun, et al.
Publicado: (2019)

Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still’s Disease From Sepsis
por: Tian, Rui, et al.
Publicado: (2021)

6. The Stillness after the storm: a challenging diagnostic and therapeutic case of adult-onset Still’s disease
por: Cronin, Owen, et al.
Publicado: (2019)

Gilbert syndrome with systemic lupus erythematosus presenting with persistent unconjugated hyperbilirubinemia: A case report
por: Ye, Naifang, et al.
Publicado: (2020)

Delayed-onset of progressive pseudorheumatoid dysplasia in a Chinese adult with a novel compound WISP3 mutation: a case report
por: Hu, Qiongyi, et al.
Publicado: (2017)

A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2017)

Publisher Correction: A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still’s Disease
por: Li, Ting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dhfrtuif5hmqkagdlpnv9jl83j